We are pleased to share that HRB will be participating in the 7th Innovators Showcase at UC Davis organized by

🍾 2024 starts with several of our colleagues traveling to talk about the applications of our TiGER-workflow 🐯. We have

As 2023 closes, at HRB we want to take a moment to reflect with you.This has been a challenging year for many biotech companies, including us.

An interesting article on “The Conversation US” criticizes biotech firms for rebranding genetic modification as “gene editing” or “precision breeding” to

📈 🌱 An interesting report elaborated by Institut Cerdà for ANOVE (Spanish Plant Breeder’s Association) shows some of the main challenges and opportunities in #agricultural#biotechnology, like the

In a recent EU ministers’ meeting, consensus on #newgenomictechniques (#NGTs) and #geneediting remained elusive. The discussions around NGTs, especially their coexistence with #organic farming and #patentability issues, are

Last week, our BD director – Gabino Sanchez-Perez – represented Hudson River Biotechnology at the kick-off Translational Biology Advisory Board (TBAB) meeting, hosted by

🔍 Two of our R&D team members – Erik Slootweg and Pavlo Grytsenko – are on their way to an

🔬 Interested in alternative production systems for #biopharmaceuticals? A recent study in #Scientific Reports showcases a #plantbased vaccine antigen effective against a bovine parasitic nematode